Concepedia

Author

Masayuki Masuda

Tokyo Medical UniversityORCID

Also Known As

BindingDB, M Masuda, M. Masuda, MASAYUKI MASUDA, Masayuki MASUDA, Masayuki Masuda, Miwa Masuda

109

Publications

2.9K

Citations

26

H-Index

80

Concepts

All Affiliations

Tokyo Medical UniversityNational Hospital Organization Hanamaki HospitalToho UniversityKeio UniversitySendai Medical Center
MM

About

Masayuki Masuda is an author at Tokyo Medical University specializing in medicine, immunology, and clinical trials.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

1.5K

2

Health Sciences

2

2

57

3

Natural Sciences

1

1

23

4

Social Sciences

1

1

65

5

Biochemistry

1

1

23

Masayuki Masuda

×

36

Publications

2.6K

Citations

26

H-Index

YearCitations

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu,

The Lancet Neurology

2021

587

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz,

The Lancet Neurology

2023

227

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge,

The Lancet Neurology

2023

213

International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r

Ted M. Burns, Reza Sadjadi, Kimiaki Utsugisawa,

Muscle & Nerve

2016

144

Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients

Masayuki Masuda, Moe Matsumoto, Sachiko Tanaka,

Journal of Neuroimmunology

2010

108

Mutations in<i>MME</i>cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

Yujiro Higuchi, Akihiro Hashiguchi, Jun‐Hui Yuan,

Annals of Neurology

2016

102

The MG‐QOL15 Japanese version: Validation and associations with clinical factors

Masayuki Masuda, Kimiaki Utsugisawa, Shigeaki Suzuki,

Muscle & Nerve

2012

98

Health‐related quality‐of‐life and treatment targets in myasthenia gravis

Kimiaki Utsugisawa, Shigeaki Suzuki, Yuriko Nagane,

Muscle & Nerve

2014

93

The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model

Seiji Miyauchi, Masayuki Masuda, Soojin Kim,

Drug Metabolism and Disposition

2018

80

Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13-15

Yoko Shibasaki, Hajime Tanaka, K Iwabuchi,

Annals of Neurology

2000

74

Page 1